Hantz Financial Services’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$180K Buy
1,937
+522
+37% +$49.1K ﹤0.01% 1155
2026
Q1
$126K Buy
1,415
+490
+53% +$50.4K ﹤0.01% 1194
2025
Q4
$88K Sell
925
-221
-19% -$22.3K ﹤0.01% 1198
2025
Q3
$113K Buy
1,146
+574
+100% +$61.4K ﹤0.01% 924
2025
Q2
$61K Buy
572
+472
+472% +$47.7K ﹤0.01% 897
2025
Q1
$9K Buy
+100
New +$11.2K ﹤0.01% 984

Other funds holding BNTX

Hantz Financial Services's BNTX Position: Q2 2026 in Review

Hantz Financial Services increased its BioNTech (BNTX) stake by 37% in Q2 2026, buying an estimated $49.1K and bringing the position to 1,937 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #1155.

Hantz Financial Services first reported a position in BNTX in Q1 2025 and has held it in 6 quarters since. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Hantz Financial Services held 1,937 shares of BioNTech worth $180K as of Q2 2026.
  • Hantz Financial Services bought 522 BioNTech shares in Q2 2026, an estimated $49.1K.
  • BioNTech made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1155 holding.
  • Hantz Financial Services first reported a position in BioNTech in Q1 2025 and has held it in 6 quarters since.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.